about
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group ReportContent Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.Trajectories of Quality of Life after Hematopoietic Cell Transplantation: Secondary Analysis of Blood and Marrow Transplant Clinical Trials Network 0902 Data.Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation.Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia.Late cardiovascular complications after hematopoietic cell transplantation.The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls.Outcomes of hematologic malignancies after unrelated donor hematopoietic cell transplantation according to place of residenceCytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis.Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma.Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.Graft-versus-host disease: state of the science.Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.Failure-free survival after initial systemic treatment of chronic graft-versus-host diseaseSibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapseHLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk categoryDouble unrelated reduced-intensity umbilical cord blood transplantation in adults.Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902.Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivorsHLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.Toll-like receptor polymorphisms in allogeneic hematopoietic cell transplantation.The outcomes of family haploidentical hematopoietic stem cell transplantation in hematologic malignancies are not associated with patient age.Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohortABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantationActivation and expansion of CD8(+) T effector cells in patients with chronic graft-versus-host disease.Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftmentBlood and marrow transplant clinical trials network state of the Science Symposium 2014National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care DeliveryRecommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia.Variation in supportive care practices in hematopoietic cell transplantation.Variation in management of immune suppression after allogeneic hematopoietic cell transplantation.Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.
P50
Q26827651-D3B4D142-A5B5-4DFD-900C-8DE6C1D34778Q30749782-B2B41483-2F2B-4207-BD2B-D3C74B731711Q31122330-EAD8AD60-AD00-4624-830E-1E3C6D7F3A39Q33366979-A7F78CD2-D878-4E91-8E5C-8B3222C59FBAQ33480401-287724DB-4C58-4C1B-A78C-0DE6BCDAC06CQ33605181-50A9231B-EB1B-4744-97F2-56761AB907EBQ33605306-0AD1E798-A200-4EA4-A24F-C91805267104Q33643509-4ED27E05-F9C9-4E25-ADFF-54050E9697CBQ33653411-C1F3D5A3-4750-4E7C-91A6-F84EED69AAC0Q33665870-439353BD-D324-43C2-88E3-A5064CA173DCQ33708469-7B7CD03D-0D24-4C90-92A5-A0AF09FD0EA8Q33886907-0ACD1674-91E1-443E-BECC-3F4E397E7905Q33977923-66F81207-F6B6-498A-BAB1-E80600D652C9Q34022803-70D690DC-10AD-42E2-9B70-3AEF5FF2DAD9Q34077787-8E06886E-635F-4E46-A662-289886A9C5DBQ34087133-8D3191B0-8F0A-46A7-B064-08B28935D00CQ34107708-CC09E48C-D246-418D-801F-77DBC50245BBQ34162647-3DEFE1FF-E994-4F73-96B6-811A953A032EQ34175457-F1236787-5F74-45A7-82B6-1458FE7D754CQ34279929-67F1FB0E-D706-4592-B0BE-1B3D1CBE0A4FQ34474243-4F7543ED-8CDF-4033-AAC8-9FCCF04B0F2AQ34711338-CBF91A95-8709-40F3-ACB9-B5AF6DEE1977Q34768153-CBE7B974-AB7A-4FFD-9198-F0A647917142Q34979770-A63676B4-C8E6-4798-9BF6-492F2E114F0CQ35041195-C845C87E-E915-443D-B044-71DBB8A4A064Q35078368-AD6AB646-BD92-483E-BCCD-93AA4585E7CEQ35085226-4AA1AC12-52EC-4773-A55D-C1016356A737Q35177449-C026780E-3248-47A6-814D-FC89E3114809Q35187185-010D43A5-43CE-4BBE-A140-FFCC6662F4BBQ35224975-35A8970D-092A-4147-85B1-0F5AACA81FB8Q35475882-419EDEE3-07F4-4200-A39B-A2911D434D29Q35591760-75113FFB-9CF1-49A2-A1DD-CE801E79C06EQ35738603-C1BDF897-553A-4392-A7E0-FF4EB3B6C9A3Q35757247-ABAEF9AC-5D3B-4E89-ADEB-6306A041FAC8Q35782852-61D18B9C-767F-4FAD-B07F-782D97C17206Q35832808-B03CD11A-BAAF-4C08-A004-43CBF51ECC35Q35836321-DB76E7E1-1451-4D0B-93AC-ABB3FA269C07Q35958194-C97C8502-1225-4A66-B9E9-4CF8B33E1B36Q35958215-2A1EFF56-4B3C-4811-A79F-813598DB8283Q35969119-7BCA04DF-39A5-43EB-9912-DE812C706AA3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stephanie J Lee
@ast
Stephanie J Lee
@en
Stephanie J Lee
@es
Stephanie J Lee
@nl
Stephanie J Lee
@sl
type
label
Stephanie J Lee
@ast
Stephanie J Lee
@en
Stephanie J Lee
@es
Stephanie J Lee
@nl
Stephanie J Lee
@sl
prefLabel
Stephanie J Lee
@ast
Stephanie J Lee
@en
Stephanie J Lee
@es
Stephanie J Lee
@nl
Stephanie J Lee
@sl
P106
P31
P496
0000-0003-2600-6390